# A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice

> **NCT05316662** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 187 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Semaglutide

## Key facts

- **NCT ID:** NCT05316662
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-06
- **Primary completion:** 2024-04-06
- **Final completion:** 2024-04-06
- **Target enrollment:** 187 (ACTUAL)
- **Last updated:** 2025-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05316662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05316662, "A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Mexico, as Part of Local Clinical Practice". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT05316662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*